IMU: Is it all too late?, page-38

Mer,

IMU, especially Lesley, has several times in her interviews hinted that the technology works. Even if they just had data from 5 people showing the immune system response we all expect, it would restore confidence. ATM the early CR at a huge discount using a CR-shark indicates either stupidity by the board or that they tried to secure funds hoping for more favourable data that would paint a better picture as the current patients outcome is not what they expected.

They need to come up with something to show they either failed or are on the road to success. ATM many holders, including me, are sensing failure.